BSE filing, NSE: ABANSENT. Summary written from the filing by ALFA Finder's alert engine.
Abans Enterprises Ltd: key numbers
- Share price
- ₹28.73
- Market cap
- ₹200.4 Cr
- Revenue (annual)
- ₹13,813 Cr
- Net profit (annual)
- ₹3.96 Cr
- P/E (TTM)
- 6.3×Sector 36.4×
- Promoter holding
- 74.56%+0.00% QoQ
- FII holding
- 20.62%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Abans Enterprises Ltd
All →Abans Enterprises Other Announcement
Abans Enterprises Ltd filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Abans Enterprises Price Movement Clarification
Abans Enterprises clarified that recent stock price movements are purely market-driven. The company confirmed no undisclosed material information exists regarding price or volume fluctuations.
Abans Enterprises Other Announcement
Abans Enterprises Ltd filed a certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026, confirming RTA compliance.
Abans Enterprises Annual General Meeting
Abans Enterprises Ltd held its 40th Annual General Meeting on September 9, 2026, where members transacted business as per the notice.
Abans Enterprises Annual Report
Abans Enterprises Limited has submitted a revised Annual Report for the financial year 2025-26 to rectify inadvertent, non-material typographical errors identified after the initial submission.
Abans Enterprises Other Announcement
Abans Enterprises initiated the dispatch of letters with web-links and QR codes for accessing its FY 2025-26 Annual Report and 40th AGM Notice to shareholders.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.